Načítá se...
Can broadly neutralizing monoclonal antibodies lead us to a hepatitis C virus vaccine?
While licensed vaccines elicit protective antibody responses against a variety of viral infections, an effective vaccine for hepatitis C virus (HCV) has remained elusive. The extraordinary genetic diversity of HCV and the ability of the virus to evade the immune response have hindered vaccine develo...
Uloženo v:
| Vydáno v: | Trends Microbiol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6421862/ https://ncbi.nlm.nih.gov/pubmed/29703495 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tim.2018.04.002 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|